-+ 0.00%
-+ 0.00%
-+ 0.00%

Scinai Immunotherapeutics announces private placement raising USD 4 million

PUBT·10/14/2026 12:03:04
Listen to the news
Scinai Immunotherapeutics announces private placement raising USD 4 million
  • Scinai Immunotherapeutics priced a private placement with a life sciences institutional investor, targeting gross proceeds of about $4 million.
  • Deal includes 2,458,334 ADSs or pre-funded warrants, sold with Series A-1 warrants at a combined price of $1.20 per ADS.
  • Series A-1 warrants cover up to 3,687,501 ADSs, carry a $1.20 exercise price, are exercisable immediately, expire in five years.
  • Separate warrant inducement covers cash exercise of April 2026 warrants for 879,194 ADSs at a reduced $1.20 exercise price.
  • Investor to receive new unregistered Series A-1 warrants for 1,318,791 ADSs; closing expected around Oct. 15, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scinai Immunotherapeutics Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: LN72016) on October 14, 2026, and is solely responsible for the information contained therein.